Annual revenue:
$781.37M+$384.78M(+97.02%)Summary
- As of today (August 4, 2025), APLS annual revenue is $781.37 million, with the most recent change of +$384.78 million (+97.02%) on December 31, 2024.
- During the last 3 years, APLS annual revenue has risen by +$714.80 million (+1073.88%).
- APLS annual revenue is now at all-time high.
Performance
APLS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$178.49M+$11.70M(+7.01%)Summary
- As of today (August 4, 2025), APLS quarterly revenue is $178.49 million, with the most recent change of +$11.70 million (+7.01%) on June 30, 2025.
- Over the past year, APLS quarterly revenue has dropped by -$21.19 million (-10.61%).
- APLS quarterly revenue is now -28.60% below its all-time high of $250.00 million, reached on December 31, 2020.
Performance
APLS Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$754.65M-$21.19M(-2.73%)Summary
- As of today (August 4, 2025), APLS TTM revenue is $754.65 million, with the most recent change of -$21.19 million (-2.73%) on June 30, 2025.
- Over the past year, APLS TTM revenue has increased by +$125.86 million (+20.02%).
- APLS TTM revenue is now -3.42% below its all-time high of $781.37 million, reached on December 31, 2024.
Performance
APLS TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
APLS Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +97.0% | -10.6% | +20.0% |
| 3 y3 years | +1073.9% | +993.6% | +680.9% |
| 5 y5 years | - | - | - |
APLS Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1073.9% | -16.0% | +993.6% | -3.4% | +900.6% |
| 5 y | 5-year | at high | +1073.9% | -28.6% | >+9999.0% | -3.4% | >+9999.0% |
| alltime | all time | at high | +1073.9% | -28.6% | >+9999.0% | -3.4% | >+9999.0% |
APLS Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $178.49M(+7.0%) | $754.65M(-2.7%) |
| Mar 2025 | - | $166.80M(-21.5%) | $775.84M(-0.7%) |
| Dec 2024 | $781.37M(+97.0%) | $212.53M(+8.0%) | $781.37M(+9.2%) |
| Sep 2024 | - | $196.83M(-1.4%) | $715.22M(+13.7%) |
| Jun 2024 | - | $199.69M(+15.9%) | $628.79M(+20.0%) |
| Mar 2024 | - | $172.32M(+17.7%) | $524.07M(+32.1%) |
| Dec 2023 | $396.59M | $146.38M(+32.6%) | $396.59M(+45.3%) |
| Sep 2023 | - | $110.40M(+16.2%) | $272.88M(+47.9%) |
| Jun 2023 | - | $94.97M(+111.8%) | $184.53M(+74.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $44.85M(+97.9%) | $105.89M(+40.4%) |
| Dec 2022 | $75.42M(+13.3%) | $22.66M(+2.8%) | $75.42M(-33.3%) |
| Sep 2022 | - | $22.06M(+35.1%) | $113.05M(+17.0%) |
| Jun 2022 | - | $16.32M(+13.5%) | $96.64M(+19.4%) |
| Mar 2022 | - | $14.38M(-76.1%) | $80.94M(+21.6%) |
| Dec 2021 | $66.56M(-73.4%) | $60.29M(+967.1%) | $66.56M(-74.0%) |
| Sep 2021 | - | $5.65M(+806.9%) | $256.27M(+2.0%) |
| Jun 2021 | - | $623.00K(-99.8%) | $251.27M(+0.2%) |
| Dec 2020 | $250.65M | $250.00M(>+9900.0%) | $250.65M(>+9900.0%) |
| Sep 2020 | - | $646.00K | $646.00K |
FAQ
- What is Apellis Pharmaceuticals, Inc. annual revenue?
- What is the all time high annual revenue for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. annual revenue year-on-year change?
- What is Apellis Pharmaceuticals, Inc. quarterly revenue?
- What is the all time high quarterly revenue for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. quarterly revenue year-on-year change?
- What is Apellis Pharmaceuticals, Inc. TTM revenue?
- What is the all time high TTM revenue for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. TTM revenue year-on-year change?
What is Apellis Pharmaceuticals, Inc. annual revenue?
The current annual revenue of APLS is $781.37M
What is the all time high annual revenue for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high annual revenue is $781.37M
What is Apellis Pharmaceuticals, Inc. annual revenue year-on-year change?
Over the past year, APLS annual revenue has changed by +$384.78M (+97.02%)
What is Apellis Pharmaceuticals, Inc. quarterly revenue?
The current quarterly revenue of APLS is $178.49M
What is the all time high quarterly revenue for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high quarterly revenue is $250.00M
What is Apellis Pharmaceuticals, Inc. quarterly revenue year-on-year change?
Over the past year, APLS quarterly revenue has changed by -$21.19M (-10.61%)
What is Apellis Pharmaceuticals, Inc. TTM revenue?
The current TTM revenue of APLS is $754.65M
What is the all time high TTM revenue for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high TTM revenue is $781.37M
What is Apellis Pharmaceuticals, Inc. TTM revenue year-on-year change?
Over the past year, APLS TTM revenue has changed by +$125.86M (+20.02%)